Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Telaprevir Achieves 65% SVR in REALIZE Study

September 9, 2010 6:46 am | News | Comments

Vertex Pharmaceuticals Incorporated announced that 65% of people overall achieved a sustained viral response (viral cure) with a telaprevir-based regimen in the Phase 3 REALIZE study, compared to 17% of people who received pegylated-interferon and ribavirin alone.

TOPICS:

Woman Receives $21M In Side Effect Suit

September 9, 2010 6:30 am | by Lynne Tuohy | News | Comments

A federal jury in New Hampshire has awarded $21 million to a woman blinded and scarred by a prescription drug she took for shoulder pain.

TOPICS:

Emergent's Trubion Buyout Given All-Clear

September 9, 2010 6:27 am | News | Comments

The planned buyout of Trubion Pharmaceuticals Inc. by Emergent BioSolutions Inc. cleared a regulatory hurdle, bringing the deal, potentially worth $135.5 million, closer to closing.

TOPICS:
Advertisement

J & J Donating $200M to UN Program

September 9, 2010 6:06 am | by Linda A. Johnson | News | Comments

Health giant Johnson & Johnson is donating about $200 million in cash and medicine to a sweeping United Nations program created to improve the health and lives of people in poor countries.

TOPICS:

Microscope Software

September 8, 2010 8:53 am | Product Releases | Comments

With the software solutions Ariol and SlidePath, Leica Microsystems now adds the ability to store, manage, analyze, and report on digital images created with the Leica SCN400 Slide Scanner or the Leica DM6000 B Research Microscope.

TOPICS:

Protein G Biosensor

September 8, 2010 8:44 am | Product Releases | Comments

ForteBio, Inc., a supplier of label-free technology, announced the launch of its Dip and Read Protein G biosensor for rapid detection and quantification of numerous types of mammalian immunoglobulin, from solution.

TOPICS:

Zyleris Launches Screening Service

September 8, 2010 8:38 am | News | Comments

Zyleris PharmaTech has announced the launch of its high-throughput formulation screening service for topical and transdermal drug development based on the company’s innovative experimentation technology.

TOPICS:

Protea Licenses New Mass Spec Tech From GWU

September 8, 2010 8:33 am | News | Comments

Protea Biosciences announced that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.

TOPICS:
Advertisement

New Solution to Cell Death Plaguing Stem Cell Research

September 8, 2010 8:25 am | News | Comments

One such obstacle frustrating stem cell researchers is "cell death" that the major types of hPS cells, including human embryonic stem cells and human induced pluripotent stem cells, mysteriously undergo when cultured as single cells, rendering them less suitable for research.

TOPICS:

Insulin Prompts Fat Cells To Take In Glucose

September 8, 2010 8:19 am | News | Comments

Using high-resolution microscopy, researchers at the National Institutes of Health have shown how insulin prompts fat cells to take in glucose in a rat model.

TOPICS:

IV Ibuprofen Lessens Morphine Use

September 8, 2010 8:15 am | News | Comments

Cumberland Pharmaceuticals Inc. announced the publication of new data supporting the safety and efficacy of Caldolor (ibuprofen) Injection in pre- and post-operative orthopedic surgery patients.

TOPICS:

KRN5500 Significantly Reduces Neuropathic Pain

September 8, 2010 8:08 am | News | Comments

DARA BioSciences announced that it presented study results from its Phase 2 multicenter, placebo controlled, double-blind, randomized dose escalation study for KRN5500 at the 13th World Congress on Pain held recently in Montreal.

TOPICS:

NIH Expands PharmGKB

September 8, 2010 8:02 am | News | Comments

To help advance research on how genes affect responses to medicines, the National Institutes of Health is spending $15 million over five years to expand a key resource, the Pharmacogenomics Knowledge Base (PharmGKB).

TOPICS:

Saphris Approved for Two New Uses

September 8, 2010 7:57 am | by Linda A. Johnson | News | Comments

Merck & Co. said its schizophrenia drug Saphris has been approved for two additional uses by the Food and Drug Administration.

TOPICS:

Healthcare Repeal Attempt Likely If Republicans Win

September 8, 2010 7:54 am | by Ricardo Alonso-Zaldivar | News | Comments

If you thought passing the health care overhaul was messy, wait until Republicans try to repeal it if they regain power this fall. It could come down to who blinks first, with some Republicans raising the prospect of a government shutdown.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading